These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 19306078)

  • 21. Expression, refolding, and characterization of human soluble BAFF synthesized in Escherichia coli.
    Cao P; Mei JJ; Diao ZY; Zhang Sq
    Protein Expr Purif; 2005 May; 41(1):199-206. PubMed ID: 15802238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral adeno-associated virus-sTRAIL gene therapy suppresses human hepatocellular carcinoma growth in mice.
    Ma H; Liu Y; Liu S; Xu R; Zheng D
    Hepatology; 2005 Dec; 42(6):1355-63. PubMed ID: 16317690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of soluble tumor necrosis factor-related apoptosis-inducing ligand concentrations after stem cell transplantation.
    Nomura S; Ishii K; Inami N; Uoshima N; Ishida H; Yoshihara T; Kitayama H; Hayashi K
    Transpl Immunol; 2007 Nov; 18(2):115-21. PubMed ID: 18005854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Anti-tumor effect of eukaryotic expressing plasmid containing soluble tumor necrotic factor-related apoptosis inducing ligand combined with human angiostatin Kringle (1 - 3) genes on human gastric cancer xenografts in nude mice].
    Sun W; Jiang Z; Xiang TX; Tao XH; Huang AL; Wang PL
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(12):841-5. PubMed ID: 19595126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-level expression and purification of recombinant huGM-CSF (9-127)/IL-6 (29-184) fusion protein in Escherichia coil.
    Sun QM; Jiang HC; Xu WM; Liu X; Dai CB; Sun MS
    Protein Expr Purif; 2005 Aug; 42(2):278-85. PubMed ID: 15935697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [High-cell density cultivation of recombinant Escherichia coli for production of TRAIL by using a 2-stage feeding strategy].
    Zhang Y; Shen YL; Xia XX; Sun AY; Wei DZ; Zhou JS; Zhang GJ; Wang LH; Jiao BH
    Sheng Wu Gong Cheng Xue Bao; 2004 May; 20(3):408-13. PubMed ID: 15971615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
    Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
    Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Construction, expression, and purification of HIV-TAT-survivin (T34A) mutant: a pro-apoptosis protein in Escherichia coli.
    Ma X; Zheng W; Wei D; Ma Y; Wang T; Wang J; Liu Q; Yang S
    Protein Expr Purif; 2006 May; 47(1):36-44. PubMed ID: 16260148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Refolding and purification of yeast carboxypeptidase Y expressed as inclusion bodies in Escherichia coli.
    Hahm MS; Chung BH
    Protein Expr Purif; 2001 Jun; 22(1):101-7. PubMed ID: 11388806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Refolding and structural characteristic of TRAIL/Apo2L inclusion bodies from different specific growth rates of recombinant Escherichia coli.
    Kang H; Sun AY; Shen YL; Wei DZ
    Biotechnol Prog; 2007; 23(1):286-92. PubMed ID: 17269700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Expression and biological activities of TRAIL fusion protein gene].
    Li J; Zheng Y; Chen H; Du L; Shu CL; Cheng Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Nov; 19(6):535-7. PubMed ID: 15182642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression, purification, and refolding of a novel immunotoxin containing humanized single-chain fragment variable antibody against CTLA4 and the N-terminal fragment of human perforin.
    Wan L; Zeng L; Chen L; Huang Q; Li S; Lu Y; Li Y; Cheng J; Lu X
    Protein Expr Purif; 2006 Aug; 48(2):307-13. PubMed ID: 16584889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression, refolding, and characterization of a novel recombinant dual human stem cell factor.
    Lu H; Zang Y; Ze Y; Zhu J; Chen T; Han J; Qin J
    Protein Expr Purif; 2005 Oct; 43(2):126-32. PubMed ID: 16139754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. L-cysteine-enhanced renaturation of bioactive soluble tumor necrosis factor ligand family member LIGHT from inclusion bodies in Escherichia coli.
    Tsuji I; Mastui H; Ito T; Kurokawa T; Shintani Y
    Protein Expr Purif; 2011 Dec; 80(2):239-45. PubMed ID: 21745574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Recombination of human HER2 gene encoding the extracellular domain and purification of fusion protein].
    Liu X; He Z; Yang F; Yu Y; Lv H; Chen Z
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Feb; 23(1):136-41. PubMed ID: 16532828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Purification and characterization of recombinant sTRAIL expressed in Escherichia coli.
    Xia XX; Shen YL; Wei DZ
    Acta Biochim Biophys Sin (Shanghai); 2004 Feb; 36(2):118-22. PubMed ID: 14970907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression and purification of soluble B lymphocyte stimulator from recombinant Escherichia coli.
    Guo QR; Tong WY; Wei DZ; Tao XY
    Prikl Biokhim Mikrobiol; 2008; 44(2):187-92. PubMed ID: 18669261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-level expression, purification and pro-apoptosis activity of HIV-TAT-survivin (T34A) mutant to cancer cells in vitro.
    Ma X; Zheng W; Wei D; Ma Y; Wang T; Wang J; Liu Q; Yang S
    J Biotechnol; 2006 May; 123(3):367-78. PubMed ID: 16406157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human umbilical cord mesenchymal stem cells as vehicles of CD20-specific TRAIL fusion protein delivery: a double-target therapy against non-Hodgkin's lymphoma.
    Yan C; Li S; Li Z; Peng H; Yuan X; Jiang L; Zhang Y; Fan D; Hu X; Yang M; Xiong D
    Mol Pharm; 2013 Jan; 10(1):142-51. PubMed ID: 23121392
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Expression and purification of recombinant Trail protein in E.coli and the optimal conditions for Trail purification].
    Cai YY; Li XY; Wu Y; DU JC; Xu X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Jun; 28(6):596-600. PubMed ID: 22691351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.